BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6182794)

  • 1. Fetal hemoglobin in women with normal and with hydatidiform molar pregnancy.
    Lee JC; Hayashi RH; Shepard MK
    Am J Hematol; 1982 Sep; 13(2):131-9. PubMed ID: 6182794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative assay of HCG, HCT and HCS in molar pregnancy.
    Tojo S; Mochizuki M; Kanazawa S
    Acta Obstet Gynecol Scand; 1974; 53(4):369-73. PubMed ID: 4474790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
    Lim YC; Chew SC; Ratnam SS
    Acta Obstet Gynecol Scand; 1976; 55(5):407-12. PubMed ID: 187001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin secretion in molar and normal pregnancy.
    Carranza-Lira S; Hernández F; Sánchez M; Murrieta S; Hernández A; Sandoval C
    Int J Gynaecol Obstet; 1998 Feb; 60(2):137-41. PubMed ID: 9509951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of human chorionic somatomammotrophin, progesterone, unconjugated oestradiol and oestriol, and alpha-foetoprotein in patients with hydatidiform moles.
    Miyakawa I; Yagi K; Nakayama M; Matsuo I; Maeyama M
    J Endocrinol; 1977 Mar; 72(3):371-8. PubMed ID: 67163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
    Dawood MY
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):729-39. PubMed ID: 169657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.